Healthcare Industry News: DePuy
News Release - May 1, 2007
Orthofix International Strengthens Senior Management Team with Promotion of Scott Dodson to President of Orthopedics Global Business Unit
Company also announces hiring of Andrew Miclot as Vice President of Marketing for Orthopedics Global Business UnitHUNTERSVILLE, N.C.--(HSMN NewsFeed)--Orthofix International N.V. (NASDAQ: OFIX ) announced today that Scott Dodson has been promoted to the position of President of the Orthopedics Global Business Unit (GBU). Mr. Dodson joined Orthofix in 2006 as the Global Vice President of Marketing for Orthopedics. Previously Mr. Dodson was Vice President of Marketing at the Endoscopy division of Boston Scientific.
"During the past year with Orthofix, Scott has been a significant contributor to the improvement of our orthopedic business," said Orthofix's Chief Executive Officer, Alan Milinazzo. "Scott is the ideal person to lead the development of our global orthopedics business and execute our long term growth strategy in this important part of our core operations."
Additionally, Orthofix announced that Andrew Miclot has joined the company as Vice President of Marketing for the Orthopedics GBU. Mr. Miclot was previously a Senior Vice President at Symmetry Medical, Inc., where he was responsible for sales, marketing and business development for two divisions with 13 global locations and almost 2,000 employees. While at Symmetry Medical, Mr. Miclot directed a number of strategic corporate initiatives, including several global acquisitions. He also led efforts to build sales infrastructure, worldwide distribution and customer service networks, and marketing and R&D functions. Prior to that, Mr. Miclot was the Director of the Medical Products Group at DePuy, an international division of Johnson and Johnson.
"Andrew is an outstanding addition to our Orthopedic GBU, where his experience in directing the implementation of various global corporate initiatives will be important as we continue to execute the organic and inorganic components of our long term growth strategy," stated Mr. Milinazzo.
About Orthofix International, N.V.
Orthofix International N.V., a global diversified orthopedic products company, offers a broad line of minimally invasive surgical, as well as non-surgical, products for the spine, orthopedics, and sports medicine market sectors that address the lifelong bone-and-joint health needs of patients of all ages, helping them achieve a more active and mobile lifestyle. Orthofix's products are widely distributed around the world to orthopedic surgeons and patients via Orthofix's sales representatives and its subsidiaries, including Breg, Inc. and Blackstone Medical, Inc., and via partnerships with other leading orthopedic product companies, including Kendall Healthcare. In addition, Orthofix is collaborating in R&D partnerships with leading medical institutions such as the Orthopedic Research and Education Foundation, Rutgers University, the Cleveland Clinic Foundation, and National Osteoporosis Institute. For more information about Orthofix, please visit www.orthofix.com.
Source: Orthofix International
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
